AARP Attorneys Join Whistleblower’s Legal Team in Fraud Case Regarding Off-label Marketing of Medical Devices

AARP announced in a press release that its attorneys will join the legal team representing whistleblower Kevin Colquitt who reported on the off-label marketing of metal biliary stents wrongfully placed in older patients to treat vascular disease.  According to AARP, “the risky devices are not approved by the Food and Drug Administration (FDA) as safe and effective to treat vascular disease, which involves narrowing of blood vessels in the legs, arms, or kidneys.”  The case is United States ex rel. Kevin N. Colquitt v. Abbott Laboratories et al., Civ. Action No. 3-06-CV-1769 (N.D. Tex.) (Judge Barbara J. Lynn).  For more information about The Employment Law Group® and its Whistleblower Law Practice, click here.

Tagged: Uncategorized